J Am Pharm Assoc (2003). 2026 Jun 17:103469. doi: 10.1016/j.japh.2026.103469. Online ahead of print. ABSTRACT BACKGROUND: Patients with opioid use disorder encounter challenges obtaining buprenorphine (BUP) at pharmacies, increasing their risk of treatment non-adherence and illicit drug use. OBJECTIVES: The purpose of this quality improvement (QI) initiative was to implement and evaluate a multi-component intervention […]